跳转至内容
Merck
CN
  • Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.

Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.

The American journal of pathology (2015-05-20)
Arick C Park, Charlotte L Phillips, Ferris M Pfeiffer, Drew A Roenneburg, John F Kernien, Sheila M Adams, Jeffrey M Davidson, David E Birk, Daniel S Greenspan
摘要

Null alleles for the COL5A1 gene and missense mutations for COL5A1 or the COL5A2 gene underlie cases of classic Ehlers-Danlos syndrome, characterized by fragile, hyperextensible skin and hypermobile joints. However, no classic Ehlers-Danlos syndrome case has yet been associated with COL5A2 null alleles, and phenotypes that might result from such alleles are unknown. We describe mice with null alleles for the Col5a2. Col5a2(-/-) homozygosity is embryonic lethal at approximately 12 days post conception. Unlike previously described mice null for Col5a1, which die at 10.5 days post conception and virtually lack collagen fibrils, Col5a2(-/-) embryos have readily detectable collagen fibrils, thicker than in wild-type controls. Differences in Col5a2(-/-) and Col5a1(-/-) fibril formation and embryonic survival suggest that α1(V)3 homotrimers, a rare collagen V isoform that occurs in the absence of sufficient levels of α2(V) chains, serve functional roles that partially compensate for loss of the most common collagen V isoform. Col5a2(+/-) adults have skin with marked hyperextensibility and reduced tensile strength at high strain but not at low strain. Col5a2(+/-) adults also have aortas with increased compliance and reduced tensile strength. Results thus suggest that COL5A2(+/-) humans, although unlikely to present with frank classic Ehlers-Danlos syndrome, are likely to have fragile connective tissues with increased susceptibility to trauma and certain chronic pathologic conditions.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
尿素, powder, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
尿素, ACS reagent, 99.0-100.5%
Supelco
尿素, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
尿素 溶液, BioUltra, ~8 M in H2O
Sigma-Aldrich
(±)-环氧丙烷, ReagentPlus®, ≥99%
Sigma-Aldrich
尿素, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
丁二酸酐, ≥99% (GC)
Sigma-Aldrich
尿素, BioUltra, Molecular Biology, 99% (T)
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
Sigma-Aldrich
(±)-环氧丙烷, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
尿素, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
尿素, suitable for electrophoresis
Sigma-Aldrich
2,4,6-三(二甲氨基甲基)苯酚, 95%
Sigma-Aldrich
尿素, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Sigma-Aldrich
尿素, meets USP testing specifications
Supelco
10% (v/v) 乙醇标准品, 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
尿素, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
2,4,6-三(二甲氨基甲基)苯酚, ≥95% (NT)
Sigma-Aldrich
尿素 溶液, 40 % (w/v) in H2O
Sigma-Aldrich
80% v/v 乙醇固定液, suitable for fixing solution (blood films)
Sigma-Aldrich
纯乙醇, 190 proof, ACS reagent, meets USP testing specifications, Excise Tax-free, Permit for use required
Sigma-Aldrich
尿素-12C, 99.9 atom % 12C
Sigma-Aldrich
纯乙醇, 200 proof, ACS reagent, meets USP testing specifications, Excise Tax-free, Permit for use required
Sigma-Aldrich
尿素, Vetec, reagent grade, 99%
Sigma-Aldrich
纯乙醇, 160 proof, Excise Tax-free, Permit for use required